Literature DB >> 20213713

Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified.

Nadine Grambauer1, Martin Schumacher, Jan Beyersmann.   

Abstract

Competing risks model time-to-first-event and the event type. Our motivating data example is the ONKO-KISS study on the occurrence of infections in neutropenic patients after stem-cell transplantation with first-event-types 'infection' and 'end of neutropenia'. The standard approach to study the effects of covariates in competing risks is to assume each event-specific hazard (ESH) to follow a proportional hazards model. However, a summarizing probability interpretation of the different event-specific effects of one covariate can be challenging. This difficulty has led to the development of the proportional subdistribution hazards model of a competing event of interest. However, one model specification usually precludes the other. Assuming proportional ESHs, we find that the subdistribution log-hazard ratio may show a pronounced time-dependency, even changing sign. Still, the subdistribution analysis is useful by estimating the least false parameter (LFP), a time-averaged effect on the cumulative event probabilities. In examples, we find that the LFP offers a robust summary of the effects on the ESHs for different observation periods, ranging from heavy censoring to no censoring at all. In particular, if there is no effect on the competing ESH, the subdistribution log-hazard ratio is close to the event-specific log-hazard ratio of interest. We reanalyze an interpretationally challenging example from the ONKO-KISS study and conduct a simulation study, where we find that the LFP is reliably estimated by the subdistribution analysis even for moderate sample sizes.

Entities:  

Mesh:

Year:  2010        PMID: 20213713     DOI: 10.1002/sim.3786

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

Review 1.  Competing risks in epidemiology: possibilities and pitfalls.

Authors:  Per Kragh Andersen; Ronald B Geskus; Theo de Witte; Hein Putter
Journal:  Int J Epidemiol       Date:  2012-01-09       Impact factor: 7.196

2.  The use and interpretation of competing risks regression models.

Authors:  James J Dignam; Qiang Zhang; Masha Kocherginsky
Journal:  Clin Cancer Res       Date:  2012-01-26       Impact factor: 12.531

3.  Estimation with Cox models: cause-specific survival analysis with misclassified cause of failure.

Authors:  Bart Van Rompaye; Shabbar Jaffar; Els Goetghebeur
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

Review 4.  Applying competing risks regression models: an overview.

Authors:  Bernhard Haller; Georg Schmidt; Kurt Ulm
Journal:  Lifetime Data Anal       Date:  2012-09-26       Impact factor: 1.588

5.  Joint Inference for Competing Risks Survival Data.

Authors:  Gang Li; Qing Yang
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

6.  Long-chain polyunsaturated fatty acids, gestation duration, and birth size: a Mendelian randomization study using fatty acid desaturase variants.

Authors:  Jonathan Y Bernard; Hong Pan; Izzuddin M Aris; Margarita Moreno-Betancur; Shu-E Soh; Fabian Yap; Kok Hian Tan; Lynette P Shek; Yap-Seng Chong; Peter D Gluckman; Philip C Calder; Keith M Godfrey; Mary Foong-Fong Chong; Michael S Kramer; Neerja Karnani; Yung Seng Lee
Journal:  Am J Clin Nutr       Date:  2018-07-01       Impact factor: 7.045

7.  Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.

Authors:  Nikolas Wada; Lisa P Jacobson; Mardge Cohen; Audrey French; John Phair; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2013-01-03       Impact factor: 4.897

8.  Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer.

Authors:  Timothy J Daskivich; Kang-Hsien Fan; Tatsuki Koyama; Peter C Albertsen; Michael Goodman; Ann S Hamilton; Richard M Hoffman; Janet L Stanford; Antoinette M Stroup; Mark S Litwin; David F Penson
Journal:  Ann Intern Med       Date:  2013-05-21       Impact factor: 25.391

9.  Direct likelihood inference on the cause-specific cumulative incidence function: A flexible parametric regression modelling approach.

Authors:  Sarwar Islam Mozumder; Mark Rutherford; Paul Lambert
Journal:  Stat Med       Date:  2017-10-02       Impact factor: 2.373

10.  Impact of comorbidities at diagnosis on prostate cancer treatment and survival.

Authors:  Katarina Luise Matthes; Manuela Limam; Giulia Pestoni; Leonhard Held; Dimitri Korol; Sabine Rohrmann
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-07       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.